PT  - JOURNAL ARTICLE
AU  - Martina Orlandi
AU  - Nicholas Landini
AU  - Cosimo Bruni
AU  - Stefano Colagrande
AU  - Marco Matucci-Cerinic
AU  - Musataka Kuwana
TI  - Infection or Autoimmunity? The Clinical Challenge of Interstitial Lung Disease in Systemic Sclerosis During the COVID-19 Pandemic
AID  - 10.3899/jrheum.200832
DP  - 2020 Dec 01
TA  - The Journal of Rheumatology
PG  - jrheum.200832
4099  - http://www.jrheum.org/content/early/2020/12/10/jrheum.200832.short
4100  - http://www.jrheum.org/content/early/2020/12/10/jrheum.200832.full
AB  - The novel coronavirus disease 2019 (COVID-19) pandemic is a world emergency that may inevitably complicate the clinical scenario of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc)1,2. The striking similarities in computed tomography (CT) between the 2 diseases make it difficult to distinguish a worsening of SSc-ILD from a COVID-19 superinfection2.